SCHEMBL2138985

SCHEMBL2138985

O=S(=O)([O-])C=Cc1ccccc1.O=S(=O)([O-])C=Cc1ccccc1.[Ca+2]

nearest known ligand 0.57

Known targets — ChEMBL curated mechanism

GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHMGCRMMP1MMP13MMP7MMP8PTGS1PTGS2ileSpolrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 6/20 0.52
LMNA P02545 4/20 0.52
NFE2L2 Q16236 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.46
ALDH1A1 P00352 2/20 0.46
HDAC3 O15379 1/20 0.46
TNKS O95271 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HCAR2 Q8TDS4 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC11 Q96DB2 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
TNKS2 Q9H2K2 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
HDAC9 Q9UKV0 1/20 0.46
HDAC5 Q9UQL6 1/20 0.46
PLIN1 O60240 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7626992 0.95 PPARG (0.52) PPARGLMNANFE2L2SMN1; SMN2ALDH1A1
SCHEMBL6436967 0.95 PPARG (0.52) PPARGLMNANFE2L2SMN1; SMN2ALDH1A1
SCHEMBL11600944 0.95 PPARG (0.52) PPARGLMNANFE2L2SMN1; SMN2ALDH1A1
SCHEMBL1565614 0.95 PPARG (0.52) PPARGLMNANFE2L2SMN1; SMN2ALDH1A1
SCHEMBL2997852 0.95 PPARG (0.52) PPARGLMNANFE2L2SMN1; SMN2ALDH1A1
SCHEMBL3002303 0.95 PPARG (0.52) PPARGLMNANFE2L2SMN1; SMN2ALDH1A1
SCHEMBL6439767 0.95 PPARG (0.52) PPARGLMNANFE2L2SMN1; SMN2ALDH1A1
Lithium Ion SCHEMBL193641 0.95 PPARG (0.52) PPARGLMNANFE2L2SMN1; SMN2ALDH1A1
SCHEMBL4339905 0.95 PPARG (0.52) PPARGLMNANFE2L2SMN1; SMN2ALDH1A1
SCHEMBL7631084 0.95 PPARG (0.52) PPARGLMNANFE2L2SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109065212-B Preparation method of conductive solution of conductive electrode and preparation method of conductive electrode 吴飞 2023-09-05 CN claimed
CN-116514208-A Gypsum flotation nitrogen and phosphorus wastewater recycling method 西南科技大学 2023-08-01 CN claimed
US-6855772-B2 Water-repellent and soil-resistant finish for textiles NANO-TEX, LLC (US) 2005-02-15 US claimed
US-6544594-B2 Durable even after multiple launderings NANO-TEX, LLC 2003-04-08 US claimed
US-20010009967-A1 Styrene sulfonate cation exchange membrane UBS AG, STAMFORD BRANCH AS COLLATERAL AGENT 2001-07-26 US claimed
US-6221248-B1 CROSSLINKING MONOMER AND METAL STYRENESULFONATE AND SOLVENTS, POTASSIUM OR SODIUM SALTS IONICS INCORPORATED 2001-04-24 US claimed
EP-1066331-A1 STYRENE SULFONATE CATION EXCHANGE MEMBRANE IONICS INCORPORATED (US) 2001-01-10 EP claimed
WO-1999048940-A1 STYRENE SULFONATE CATION EXCHANGE MEMBRANE IONICS, INCORPORATED (US) 1999-09-30 WO claimed
JP-11292769-A None JP disclosed
EP-4682139-A1 AMMONIUM STYRENE SULFONATE COMPOSITION WITH EXCELLENT STORAGE STABILITY AND PRODUCTION METHOD THEREFOR Tosoh Finechem Corporation (JP) 2026-01-21 EP disclosed
US-12516143-B2 Polystyrene-based polyampholyte having upper critical solution temperature, and application for same TOSOH FINECHEM CORPORATION (JP) 2026-01-06 US disclosed
CN-119255705-A Antiviral resin material, method for producing antiviral resin molded article, and antiviral resin molded article 积水化学工业株式会社 2025-01-03 CN disclosed
WO-2024190261-A1 AMMONIUM STYRENE SULFONATE COMPOSITION WITH EXCELLENT STORAGE STABILITY AND PRODUCTION METHOD THEREFOR 東ソー・ファインケム株式会社 2024-09-19 WO disclosed
CN-113597439-B Amphoteric polyelectrolytes of novel polystyrene substrates with highest critical co-solvent temperature and use thereof 东曹精细化工株式会社 2024-08-02 CN disclosed
US-6344584-B2 COMBINING IN A POLAR ORGANIC SOLVENT A CROSSLINKING MONOMER AND A STYRENESULFONIC ACID METAL SALT BOTH SOLUBLE IN THE SOLVENT TO ALLOW COPOLYMERIZATION; LITHIUM STYRENESULFONATE COPOLYMER FOR EXAMPLE; FOR ELECTRODIALYSIS IONICS, INCORPORATED 2002-02-05 US disclosed
US-20010009967-A1 Styrene sulfonate cation exchange membrane UBS AG, STAMFORD BRANCH AS COLLATERAL AGENT 2001-07-26 US disclosed
US-6221248-B1 CROSSLINKING MONOMER AND METAL STYRENESULFONATE AND SOLVENTS, POTASSIUM OR SODIUM SALTS IONICS INCORPORATED 2001-04-24 US disclosed
EP-1066331-A1 STYRENE SULFONATE CATION EXCHANGE MEMBRANE IONICS INCORPORATED (US) 2001-01-10 EP disclosed
JP-H11292769-A HYPERPOTASSEMIA-IMPROVING AGENT COMPOSITION TOYO SEIYAKU KASEI KK 1999-10-26 JP disclosed
WO-1999048940-A1 STYRENE SULFONATE CATION EXCHANGE MEMBRANE IONICS, INCORPORATED (US) 1999-09-30 WO disclosed